Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.26
Delayed Data
As of Mar 29
 +0.38 / +4.82%
Today’s Change
6.47
Today|||52-Week Range
16.30
+15.36%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close7.88
Today’s open7.89
Day’s range7.82 - 8.42
Volume606,204
Average volume (3 months)674,532
Market cap$317.5M
Dividend yield--
Data as of 3:59pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book2.64

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.01+0.18%
OBSVObseva SA-0.38-3.46%
TTPHTetraphase Pharmaceu...+0.43+5.22%
NERVMinerva Neuroscience...+0.20+2.31%
Data as of 3:59pm ET, 03/29/2017

Financials

Last reporting dateMarch 30, 2017
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts


Search for Jobs